News & Articles

First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes

An insider’s look into the bottlenecks and challenges associated with manufacturing and supply chain workflows within lateral flow diagnostics

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

Explore ways to improve time to result in critical pathways such as sepsis

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

Explore topics such as rapid antimicrobial resistance testing and analysis of viral vectors to Raman spectroscopy and high-performance thin-layer chromatography

Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform

Dr. Chris Mason shares his extensive research into the SARS-CoV-2 immune response and the similarities experienced by astronauts landing back on Earth

Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage

Watch this on-demand webinar with Dr. Petter Brodin to learn about new insights into the immune response to SARS-CoV-2

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Susie Harborth explores what it takes to be a scientist entrepreneur and highlights the technology driving innovation in bioscience

Two different dosing regimens demonstrated efficacy with one showing a better profile